Seco-neokadsuranic acid A

CAS No. 124817-74-9

Seco-neokadsuranic acid A( ——— )

Catalog No. M38371 CAS No. 124817-74-9

Seco-neokadsuranic acid A is a triterpene acid isolated from Kadsura coccinea.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 681 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Seco-neokadsuranic acid A
  • Note
    Research use only, not for human use.
  • Brief Description
    Seco-neokadsuranic acid A is a triterpene acid isolated from Kadsura coccinea.
  • Description
    Seconeokadsuranic acid A is a natural product.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    124817-74-9
  • Formula Weight
    468.678
  • Molecular Formula
    C30H44O4
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Liang CQ, et al. Kadcoccinic Acids A-J, Triterpene Acids from Kadsura coccinea. J Nat Prod. 2015 Aug 28;78(8):2067-73.?
molnova catalog
related products
  • γ-Asarone

    γ-Asarone, a phenylpropene, shows strong correlation with the biological activities (anti-oxidative, anti-inflammatory and neurotrophic effects).

  • Pseudolaric acid C-O...

    Pseudolaric acid C-O-β-D-glucopyranoside

  • Syk Inhibitor II hyd...

    The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.